| human | Q5 |
| P6178 | Dimensions author ID | 012321307677.82 |
| P496 | ORCID iD | 0000-0001-6570-3557 |
| P1053 | ResearcherID | Y-6342-2019 |
| P1153 | Scopus author ID | 7101944017 |
| P69 | educated at | Complutense University of Madrid | Q219694 |
| P108 | employer | Instituto de Investigaciones Biomédicas Alberto Sols | Q5918253 |
| Georgetown University | Q333886 | ||
| University of Navarre | Q926068 | ||
| P106 | occupation | researcher | Q1650915 |
| Q40571158 | 5'-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. |
| Q45867197 | A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver |
| Q96118167 | A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma |
| Q41634855 | A phosphatidylinositol-linkage-deficient T-cell mutant contains insulin-sensitive glycosyl-phosphatidylinositol |
| Q38181861 | Amphiregulin |
| Q96949744 | Amphiregulin Aggravates Glomerulonephritis via Recruitment and Activation of Myeloid Cells |
| Q40267021 | Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. |
| Q36744940 | Amphiregulin: a new growth factor in hepatocarcinogenesis. |
| Q45881009 | Amphiregulin: an early trigger of liver regeneration in mice. |
| Q44569328 | Authors' response: observations suggesting bioactive Fgf15 is not present in mouse blood. |
| Q39436018 | Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications. |
| Q92800121 | Chromatin dynamics during liver regeneration |
| Q92131026 | Current and innovative emerging therapies for porphyrias with hepatic involvement |
| Q112637082 | DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis |
| Q73669364 | DNA methylation and histone acetylation of rat methionine adenosyltransferase 1A and 2A genes is tissue-specific |
| Q91936622 | Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis |
| Q46937417 | Differential regulation of the JNK/AP-1 pathway by S-adenosylmethionine and methylthioadenosine in primary rat hepatocytes versus HuH7 hepatoma cells. |
| Q33762936 | Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies |
| Q104477149 | Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis |
| Q90266644 | Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma |
| Q38996610 | Emerging therapies for acute intermittent porphyria. |
| Q46640064 | Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice |
| Q45881741 | Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats |
| Q38161361 | Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer. |
| Q39252001 | Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism. |
| Q98202479 | Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities |
| Q90791744 | Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib |
| Q93194997 | Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis |
| Q100759541 | Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? |
| Q124959394 | FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted |
| Q39156500 | Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis. |
| Q50934377 | Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. |
| Q64973345 | Fibroblast growth factors 19 and 21 in acute liver damage. |
| Q53213230 | Further evidence on the janus-faced nature of the epidermal growth factor receptor: From liver regeneration to hepatocarcinogenesis. |
| Q33194484 | GARBAN: genomic analysis and rapid biological annotation of cDNA microarray and proteomic data. |
| Q30454129 | Glycosyl-phosphatidylinositol/inositol phosphoglycan: a signaling system for the low-affinity nerve growth factor receptor |
| Q47576283 | Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. |
| Q45405874 | Hepatitis B virus x protein and pin1 in liver cancer: "les liaisons dangereuses". |
| Q99725449 | Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment |
| Q73853309 | Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes: role in liver regeneration |
| Q28576522 | Identification of argininosuccinate lyase as a hypoxia-responsive gene in rat hepatocytes |
| Q38944998 | Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development |
| Q44807387 | Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. |
| Q42718037 | Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences. |
| Q73089674 | Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis |
| Q36172614 | Influence of impaired liver methionine metabolism on the development of vascular disease and inflammation. |
| Q52671690 | Inhibiting Cytokinesis in the Liver: A New Way to Reduce Tumor Development. |
| Q43574315 | Inhibition of liver methionine adenosyltransferase gene expression by 3-methylcolanthrene: protective effect of S-adenosylmethionine. |
| Q67703603 | Insulin-Like Effects of Inositol Phosphate-Glycan on Messenger RNA Expression in Rat Hepatocytes |
| Q57098739 | Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk |
| Q42680714 | Isolation and characterization of SpTRK, a gene from schizosaccharomyces pombe predicted to encode a K+ transporter protein |
| Q46494471 | L-Arginine decreases fluid-percussion injury-induced neuronal nitrotyrosine immunoreactivity in rats. |
| Q52720843 | LKB1: Controlling Quiescence and Genomic Integrity at Home. |
| Q45871828 | Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice. |
| Q40907508 | Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation. |
| Q82486866 | Long distance calling for liver regeneration: Identification of neuroendocrine signalling pathways activated after partial hepatectomy |
| Q96111263 | Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma |
| Q38760592 | MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer |
| Q50451829 | Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14. |
| Q38895324 | Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis |
| Q45857193 | Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair |
| Q64040321 | Messenger RNA therapy for rare genetic metabolic diseases |
| Q28290336 | Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma |
| Q35864131 | Methylthioadenosine. |
| Q57107966 | MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis |
| Q103824406 | Multi-Omics Integration Highlights the Role of Ubiquitination in CCl4-Induced Liver Fibrosis |
| Q45971540 | New mechanisms involving the EGFR and FGF15/19 systems in liver regeneration and carcinogenesis. |
| Q50243417 | New molecular interactions of c-Myc in cholangiocarcinoma may open new therapeutic opportunities. |
| Q36519041 | New therapies for hepatocellular carcinoma. |
| Q80551301 | Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury |
| Q28476642 | Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice |
| Q39037282 | Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes. |
| Q45888087 | Oxidation of specific methionine and tryptophan residues of apolipoprotein A-I in hepatocarcinogenesis. |
| Q38638764 | Physiological and enzymatic alterations in sesame seeds submitted to different osmotic potentials. |
| Q96637432 | Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach |
| Q50972322 | Platelet-derived growth factor D: a new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts. |
| Q37580201 | Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease. |
| Q47750006 | Prioritizing Popular Proteins in Liver Cancer: Remodelling One-Carbon Metabolism. |
| Q28567709 | Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF |
| Q59463876 | Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation |
| Q92265719 | Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting |
| Q62727088 | Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma |
| Q74133491 | Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes |
| Q38531851 | Regulation of hepatocyte identity and quiescence. |
| Q77335023 | S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes |
| Q34482345 | S-Adenosylmethionine: a control switch that regulates liver function. |
| Q43875821 | S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. |
| Q28575436 | S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver |
| Q63884152 | SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer |
| Q32068886 | Secretion of neu differentiation factor-like polypeptides by cph-transformed fibroblasts: cloning and characterization of Syrian hamster neuregulin cDNAs. |
| Q57457475 | Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis |
| Q47707134 | Specific interaction of methionine adenosyltransferase with free radicals. |
| Q90072793 | Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability |
| Q64230069 | Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins |
| Q41205843 | Splicing regulator SLU7 is essential for maintaining liver homeostasis |
| Q38799990 | Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression |
| Q57295544 | Systemic messenger RNA as an etiological treatment for acute intermittent porphyria |
| Q90357133 | Targeting CCL2/CCR2 in Tumor-Infiltrating Macrophages: A Tool Emerging Out of the Box Against Hepatocellular Carcinoma |
| Q38169563 | The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis |
| Q52927241 | The FXR-FGF19 Gut-Liver Axis as a Novel "Hepatostat". |
| Q48292789 | The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells. |
| Q39789837 | The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression. |
| Q39960326 | The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. |
| Q37476452 | The epidermal growth factor receptor: a link between inflammation and liver cancer. |
| Q36714512 | The response of the hepatocyte to ischemia. |
| Q38646109 | The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma |
| Q54333861 | Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease. |
| Q77669485 | Transformed but not normal hepatocytes express UCP2 |
| Q53647305 | Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice. |
| Q45882973 | Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. |
| Q42548403 | delta-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat. |
Search more.